Convatec me+ Companion™ App offers support for millions of intermittent catheter users

New free app offers users a practical tool to ensure their cathing journey starts smoothly 

Bridgewater, N.J., US, 1 August 2024 — Convatec, a leading medical products and technologies company, has launched a free digital app in the United States to support new intermittent catheter users and their healthcare professionals. Through our Convatec me+ Companion™ App, users can conveniently log beverage intake and urine output on their mobile device, set hydration goals, log leaks, and even create customised summary reports to download, print, and share. The app also offers access to Convatec Continence Care’s me+ support program, providing users with educational tools, resources, and support at their fingertips. We plan to expand the app to other markets in 2025.

Seth Segel, President & Chief Operating Officer, Continence Care & Home Services Group at Convatec, said: “New catheter users can be overwhelmed by changes in their lives. Often, they have basic questions and anxiety about fluid consumption patterns and their cathing frequency and efficacy. Similarly, their clinicians have asked for quick insights to help their patients ease into their new lifestyle effectively and smoothly. Having worked directly with end-users and healthcare professionals, we are excited to offer the Convatec me+ Companion app to solve these pain points for both audiences. This resource is just another example of how Convatec brings to life its forever caring promise with real-world solutions.” 

Proper hydration is a key factor in preventing and managing conditions like Urinary Tract Infections (UTIs), kidney stones, and dehydration-related complications. The me+ Companion™ app is designed to offer a confidential, simple solution for both consumers and HCP’s. The app is now available to download and use from the App Store, or on Google Play.

About me+™
Launched in 2014, our me+™ program operates throughout Asia, Latin America, Europe and the US and aims to support people managing chronic conditions to help them enjoy their lives as well as support for clinicians and caregivers. The program provides access to product samples, a dedicated team of nurses over the phone and a range of online resources covering lifestyle tips and advice, educational tools and peer-to-peer support related to ostomy care and continence care. For more information, visit https://www.convatec.com/continence-care/meplus-support-and-services

Continence Care
It is easy to find trusted solutions among the Convatec Continence Care portfolio of GentleCath™ and Cure™ innovative intermittent catheters for men, women, and children. Advanced technologies and proprietary features are designed to provide a safe, comfortable, and convenient cathing experience – to help reduce the risk of infection. For more information visit https://www.convatec.com/continence-care

Contact

Investor Relations: IR@convatec.com   
Media: MediaRelations@convatec.com

Trade/Sector media megan.chintalla@convatec.com 

About Convatec 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec’s revenues in 2023 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit  http://www.convatecgroup.com

 AP-70423-USA-ENGU-v1